Cargando…

CT features of HER2-mutant lung adenocarcinomas

OBJECTIVES: To describe the radiological phenotype of HER2-mutant lung cancers on CT at presentation. METHODS: Eligible patients with lung adenocarcinomas with HER2 mutations were stage-matched with two control groups (EGFR- and KRAS-mutant groups). Evaluated CT features of the primary tumor include...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sawan, Peter, Plodkowski, Andrew J., Li, Angela E., Li, Bob T., Drilon, Alexander, Capanu, Marinela, Ginsberg, Michelle S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382989/ https://www.ncbi.nlm.nih.gov/pubmed/29906786 http://dx.doi.org/10.1016/j.clinimag.2018.05.028

Ejemplares similares

Pancreatic adenocarcinoma: insights into patterns of recurrence and disease behavior
por: Sahin, Ibrahim H., et al.
Publicado: (2018)

CT features and disease spread patterns in ROS1-rearranged lung adenocarcinomas: comparison with those of EGFR-mutant or ALK-rearranged lung adenocarcinomas
por: Woo, Jung Han, et al.
Publicado: (2020)

HER kinase inhibition in patients with HER2- and HER3-mutant cancers
por: Hyman, David M., et al.
Publicado: (2018)

Exceptional responders with invasive mucinous adenocarcinomas: a phase 2 trial of bortezomib in patients with KRAS G12D-mutant lung cancers
por: Drilon, Alexander, et al.
Publicado: (2019)

A Phase 2 Single Arm Trial of Cabozantinib in Patients with Advanced RET-Rearranged Lung Cancers
por: Drilon, Alexander, et al.
Publicado: (2016)

Integrative analysis of functional genomic annotations and sequencing data to identify rare causal variants via hierarchical modeling
por: Capanu, Marinela, et al.
Publicado: (2015)

COVID-19 in patients with cancer: can baseline radiologic severity and early evolution predict clinical outcomes?
por: Perez-Johnston, Rocio, et al.
Publicado: (2021)

Detection of COVID-19 pulmonary manifestations with radiotherapy simulation CT imaging()
por: Wu, Abraham J., et al.
Publicado: (2023)

CT Radiomics Combined With Clinicopathological Features to Predict Invasive Mucinous Adenocarcinoma in Patients With Lung Adenocarcinoma
por: Zhang, Junjie, et al.
Publicado: (2023)

Outcomes and Molecular Features of Brain Metastasis in Gastroesophageal Adenocarcinoma
por: Tsai, Charlton, et al.
Publicado: (2022)

Targeting HER2 Exon 20 Insertion–Mutant Lung Adenocarcinoma with a Novel Tyrosine Kinase Inhibitor Mobocertinib
por: Han, Han, et al.
Publicado: (2021)

Contrast-Enhanced CT Parameters of Gastric Adenocarcinoma: Can Radiomic Features Be Surrogate Biomarkers for HER2 Over-Expression Status?
por: Wang, Na, et al.
Publicado: (2020)

Retrospective study of EGFR‐mutant lung adenocarcinoma with bone metastatic clinical features
por: Gu, Liyan, et al.
Publicado: (2022)

Mutant HER2 needs mutant HER3 to be an effective oncogene
por: Trenker, Raphael, et al.
Publicado: (2021)

CT features and quantitative analysis of subsolid nodule lung adenocarcinoma for pathological classification prediction
por: Li, Xiaohu, et al.
Publicado: (2020)

Value of CT features for predicting EGFR mutations and ALK positivity in patients with lung adenocarcinoma
por: Han, Xiaoyu, et al.
Publicado: (2021)

Outcomes of Pemetrexed-based chemotherapies in HER2-mutant lung cancers
por: Wang, Yan, et al.
Publicado: (2018)

Clinicopathological features of patients with transformation from EGFR mutant lung adenocarcinoma to small cell lung cancer
por: Bai, Wenwen, et al.
Publicado: (2021)

CT features associated with EGFR mutations and ALK positivity in patients with multiple primary lung adenocarcinomas
por: Han, Xiaoyu, et al.
Publicado: (2020)

Circulating Tumor and Invasive Cell Gene Expression Profile Predicts Treatment Response and Survival in Pancreatic Adenocarcinoma
por: Yu, Kenneth H., et al.
Publicado: (2018)

Pancreatic cancer stem cells may define tumor stroma characteristics and recurrence patterns in pancreatic ductal adenocarcinoma
por: Askan, Gokce, et al.
Publicado: (2021)

CT Features of Stage IA Invasive Mucinous Adenocarcinoma of the Lung and Establishment of a Prediction Model
por: Zhang, Xiuming, et al.
Publicado: (2022)

Clinical outcomes of patients with HER2-mutant advanced lung cancer: chemotherapies versus HER2-directed therapies
por: Zhou, Jiebai, et al.
Publicado: (2020)

Clinicopathological and CT features of tumor spread through air space in invasive lung adenocarcinoma
por: Qin, Lili, et al.
Publicado: (2022)

Rate and risk factors for AKI after CT scans in a cancer cohort
por: Latcha, Sheron, et al.
Publicado: (2019)

Atypical lung feature on chest CT in a lung adenocarcinoma cancer patient infected with COVID-19
por: Qu, J., et al.
Publicado: (2020)

Automatic detection of small lung nodules on CT utilizing a local density maximum algorithm
por: Zhao, Binsheng, et al.
Publicado: (2003)

EGFR Mutation Status and Subtypes Predicted by CT-Based 3D Radiomic Features in Lung Adenocarcinoma
por: Chen, Quan, et al.
Publicado: (2022)

Predictors of CT Morphologic Features to Identify Spread Through Air Spaces Preoperatively in Small-Sized Lung Adenocarcinoma
por: Qi, Lin, et al.
Publicado: (2021)

The frequency and clinical impact of HER2 alterations in lung adenocarcinoma
por: Kim, Eun Kyung, et al.
Publicado: (2017)

Application of CT radiomics features to predict the EGFR mutation status and therapeutic sensitivity to TKIs of advanced lung adenocarcinoma
por: Yang, Chunsheng, et al.
Publicado: (2020)

Invasive mucinous adenocarcinoma of the lung: Serial CT findings, clinical features, and treatment and survival outcomes
por: Beck, Kyongmin Sarah, et al.
Publicado: (2020)

Typical CT and MRI Features of Mucinous Rectal Adenocarcinoma
por: Ryoo, Jin-A, et al.
Publicado: (2019)

Predicting EGFR mutation subtypes in lung adenocarcinoma using (18)F-FDG PET/CT radiomic features
por: Liu, Qiufang, et al.
Publicado: (2020)

Prevalence and Clinicopathological Characteristics of HER2 and BRAF Mutation in Chinese Patients with Lung Adenocarcinoma
por: Shan, Ling, et al.
Publicado: (2015)

EGFR-Mutant Lung Adenocarcinoma Mimicking a Pneumonia
por: Taus, Álvaro, et al.
Publicado: (2012)

Characteristics of the immunogenicity and tumor immune microenvironment in HER2-amplified lung adenocarcinoma
por: Wang, Qinyang, et al.
Publicado: (2022)

CT radiomics model combined with clinical and radiographic features for discriminating peripheral small cell lung cancer from peripheral lung adenocarcinoma
por: Wang, Jingting, et al.
Publicado: (2023)

Entrectinib: an orally available, selective tyrosine kinase inhibitor for the treatment of NTRK, ROS1, and ALK fusion-positive solid tumors
por: Liu, Dazhi, et al.
Publicado: (2018)

Deep CNN Model Using CT Radiomics Feature Mapping Recognizes EGFR Gene Mutation Status of Lung Adenocarcinoma
por: Zhang, Baihua, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pvaaafct67gf0k2h94000e98pm